• Which one is better at controlling lupus: Belimumab or Anifrolumab?

  • Nov 7 2023
  • Duración: 13 m
  • Podcast

Which one is better at controlling lupus: Belimumab or Anifrolumab? Por arte de portada

Which one is better at controlling lupus: Belimumab or Anifrolumab?

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Dr. Anna Wolska sits down with experts, Dr. Michelle Petri and Dr. Nick Ballew, analyzing the effectiveness of SLE treatments Belimumab and Anifrolumab. The conversation delves into their meticulous study, where they examined the 52-week SLE Responder Index (SRI)-4 responses, providing crucial data for informed lupus patient care. The study data, based on rigorous randomized trials and systematic literature reviews, offers clinicians invaluable insights into treatment decisions for people living with lupus.

    Read the published article: http://dx.doi.org/10.1136/lupus-2023-000907
    Más Menos
activate_primeday_promo_in_buybox_DT
Enfermedades Físicas Hygiene & Healthy Living
Más Menos

Lo que los oyentes dicen sobre Which one is better at controlling lupus: Belimumab or Anifrolumab?

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles